» Articles » PMID: 8006002

Identification of Type I Receptors for Osteogenic Protein-1 and Bone Morphogenetic Protein-4

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1994 Jun 24
PMID 8006002
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

Bone morphogenetic proteins (BMPs) are multifunctional proteins, structurally related to transforming growth factor-beta (TGF-beta) and activin. TGF-beta and activin exert their effects by forming heteromeric complexes of type I and type II serine/threonine kinase receptors. We have previously identified a series of type I serine/threonine kinase receptors, termed activin receptor-like kinase (ALK)-1 to -6. ALK-5 is a TGF-beta type I receptor, whereas ALK-2 and ALK-4 are activin type I receptors. Here we investigated the binding of proteins in the BMP family to ALKs. In transfected COS cells, the binding of osteogenic protein (OP)-1 and BMP-4 to certain ALKs was observed in the absence of type II receptors, and their binding was increased after co-transfection of a BMP type II receptor from Caenorhabditis elegans, DAF-4. OP-1 bound to ALK-2 and ALK-6 efficiently, and to ALK-3 less efficiently, whereas BMP-4 bound to ALK-3 and ALK-6 efficiently. Similarly, OP-1 bound to ALK-2, ALK-3, and/or ALK-6 in various nontransfected cell lines, although the binding profiles were different between different cell types. BMP-4 bound to ALK-3 in MC3T3-E1 osteoblasts and human foreskin fibroblasts. These results suggest that ALK-3 and ALK-6 are type I receptors for OP-1 and BMP-4; in addition, ALK-2 is a type I receptor shared by activin and OP-1, but not by BMP-4.

Citing Articles

The BMP Signaling Pathway: Bridging Maternal-Fetal Crosstalk in Early Pregnancy.

Yang S, Gan J, Xu H, Shi J, Wang J, Zhang X Reprod Sci. 2025; .

PMID: 39821798 DOI: 10.1007/s43032-024-01777-4.


Capitella teleta gets left out: possible evolutionary shift causes loss of left tissues rather than increased neural tissue from dominant-negative BMPR1.

Webster N, Meyer N Neural Dev. 2024; 19(1):4.

PMID: 38698415 PMC: 11067212. DOI: 10.1186/s13064-024-00181-7.


BMP-4 and BMP-7 Inhibit EMT in a Model of Anterior Subcapsular Cataract in Part by Regulating the Notch Signaling Pathway.

Jiang F, Qin Y, Yang Y, Li Z, Cui B, Ju R Invest Ophthalmol Vis Sci. 2023; 64(4):12.

PMID: 37043340 PMC: 10103728. DOI: 10.1167/iovs.64.4.12.


Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.

Ganjoo S, Puebla-Osorio N, Nanez S, Hsu E, Voss T, Barsoumian H Front Immunol. 2022; 13:1033642.

PMID: 36353620 PMC: 9638036. DOI: 10.3389/fimmu.2022.1033642.


Engineering of a Long-Acting Bone Morphogenetic Protein-7 by Fusion with Albumin for the Treatment of Renal Injury.

Takano M, Toda S, Watanabe H, Fujimura R, Nishida K, Bi J Pharmaceutics. 2022; 14(7).

PMID: 35890230 PMC: 9316787. DOI: 10.3390/pharmaceutics14071334.